Dr. Warren Chang, MD

NPI: 1083674550
Total Payments
$4,734
2024 Payments
$1,421
Companies
26
Transactions
216
Medicare Patients
3,053
Medicare Billing
$883,281

Payment Breakdown by Category

Food & Beverage$4,676 (98.8%)
Education$58.62 (1.2%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $4,676 213 98.8%
Education $58.62 3 1.2%

Top Paying Companies

Company Total Records Latest Year
AstraZeneca Pharmaceuticals LP $1,055 50 $0 (2024)
Amgen Inc. $681.27 25 $0 (2024)
Otsuka America Pharmaceutical, Inc. $398.74 18 $0 (2024)
Fresenius USA Marketing, Inc. $343.62 19 $0 (2024)
Mallinckrodt Hospital Products Inc. $323.92 13 $0 (2024)
Janssen Pharmaceuticals, Inc $260.61 8 $0 (2024)
Bayer Healthcare Pharmaceuticals Inc. $211.56 11 $0 (2023)
Relypsa, Inc. $208.30 20 $0 (2019)
Vifor Pharma, Inc. $167.29 7 $0 (2024)
Otsuka Pharmaceutical Development & Commercialization, Inc. $131.55 5 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $1,421 58 AstraZeneca Pharmaceuticals LP ($258.31)
2023 $1,138 45 AstraZeneca Pharmaceuticals LP ($234.07)
2022 $384.08 21 AstraZeneca Pharmaceuticals LP ($117.12)
2021 $658.88 31 AstraZeneca Pharmaceuticals LP ($185.71)
2020 $376.66 21 AstraZeneca Pharmaceuticals LP ($260.26)
2019 $460.12 27 Janssen Pharmaceuticals, Inc ($223.66)
2018 $163.98 6 ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($70.83)
2017 $131.14 7 Fresenius USA Marketing, Inc. ($40.34)

All Payment Transactions

216 individual payment records from CMS Open Payments — Page 1 of 9

Date Company Product Nature Form Amount Type
12/19/2024 Otsuka America Pharmaceutical, Inc. JYNARQUE (Drug) Food and Beverage In-kind items and services $22.92 General
Category: NEPHROLOGY
12/12/2024 Travere Therapeutics, Inc. Food and Beverage In-kind items and services $35.21 General
12/06/2024 Mallinckrodt Hospital Products Inc. ACTHAR (Biological) Food and Beverage In-kind items and services $31.89 General
Category: IMMUNOLOGY
11/23/2024 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Food and Beverage In-kind items and services $28.77 General
Category: Cardiovascular and Metabolism
11/22/2024 Lilly USA, LLC JARDIANCE (Drug) Food and Beverage In-kind items and services $30.99 General
Category: Diabetes
11/21/2024 Amgen Inc. TAVNEOS (Drug) Food and Beverage In-kind items and services $17.05 General
Category: Inflammation
11/16/2024 Vifor Pharma, Inc. Veltassa (Drug) Food and Beverage In-kind items and services $34.70 General
Category: Hyperkalemia
11/09/2024 Mallinckrodt Hospital Products Inc. ACTHAR (Biological) Food and Beverage In-kind items and services $34.88 General
Category: IMMUNOLOGY
11/08/2024 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Food and Beverage In-kind items and services $28.35 General
Category: Cardiovascular and Metabolism
11/05/2024 Novartis Pharmaceuticals Corporation Fabhalta (Drug) Food and Beverage In-kind items and services $34.76 General
Category: Immunology
10/24/2024 Novo Nordisk Inc Ozempic (Drug), Rybelsus Food and Beverage In-kind items and services $19.10 General
Category: Diabetes
10/18/2024 Mallinckrodt Hospital Products Inc. ACTHAR (Biological) Food and Beverage In-kind items and services $27.55 General
Category: IMMUNOLOGY
10/10/2024 Fresenius USA Marketing, Inc. Velphoro (Drug) Food and Beverage In-kind items and services $22.32 General
Category: Phosphate binder for ESRD
10/03/2024 Novo Nordisk Inc Ozempic (Drug), Rybelsus Food and Beverage In-kind items and services $19.10 General
Category: Diabetes
09/28/2024 Mallinckrodt Hospital Products Inc. ACTHAR (Biological) Food and Beverage In-kind items and services $23.61 General
Category: IMMUNOLOGY
09/13/2024 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Food and Beverage In-kind items and services $27.96 General
Category: Cardiovascular and Metabolism
09/07/2024 Novartis Pharmaceuticals Corporation Fabhalta (Drug) Food and Beverage In-kind items and services $31.55 General
Category: Immunology
09/05/2024 Vifor Pharma, Inc. Veltassa (Drug) Food and Beverage In-kind items and services $30.50 General
Category: Hyperkalemia
08/30/2024 Novartis Pharmaceuticals Corporation Fabhalta (Drug) Food and Beverage In-kind items and services $30.94 General
Category: Immunology
08/29/2024 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Food and Beverage In-kind items and services $21.35 General
Category: Cardiovascular and Metabolism
08/22/2024 Boehringer Ingelheim Pharmaceuticals, Inc. JARDIANCE (Drug) Food and Beverage In-kind items and services $24.91 General
Category: DIABETES
08/16/2024 CALLIDITAS THERAPEUTICS US INC. TARPEYO (Drug) Food and Beverage In-kind items and services $24.97 General
Category: Nephrology
08/16/2024 OPKO Pharmaceuticals, LLC RAYALDEE (Drug) Education In-kind items and services $18.87 General
Category: NEPHROLOGY
08/09/2024 Amgen Inc. KRYSTEXXA (Biological) Food and Beverage In-kind items and services $14.74 General
Category: Inflammation/Rare Disease
08/09/2024 Amgen Inc. KRYSTEXXA (Biological) Food and Beverage In-kind items and services $14.41 General
Category: Inflammation/Rare Disease

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 10 648 1,370 $525,936 $177,821
2022 11 723 1,656 $581,715 $189,859
2021 14 802 2,048 $673,749 $255,424
2020 13 880 2,511 $689,151 $260,176
Total Patients
3,053
Total Services
7,585
Medicare Billing
$883,281
Procedure Codes
49

All Medicare Procedures & Services

49 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
90960 Dialysis services, 4 or more physician visits per month (20 years or older) Office 2023 35 169 $133,510 $54,539 40.9%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 143 327 $97,446 $23,468 24.1%
99291 Critical care, first 30-74 minutes Facility 2023 45 122 $76,372 $23,153 30.3%
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes Facility 2023 104 210 $55,020 $21,996 40.0%
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes Facility 2023 108 211 $36,714 $15,002 40.9%
99223 Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes Facility 2023 72 76 $29,032 $11,413 39.3%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2023 56 122 $50,752 $9,642 19.0%
90961 Dialysis services, 2-3 physician visits per month (20 years or older) Office 2023 15 36 $23,760 $9,586 40.3%
90935 Hemodialysis procedure with physician evaluation Facility 2023 47 74 $11,692 $4,601 39.4%
99205 New patient office or other outpatient visit, 60-74 minutes Office 2023 23 23 $11,638 $4,422 38.0%
90960 Dialysis services, 4 or more physician visits per month (20 years or older) Office 2022 47 188 $152,920 $60,456 39.5%
99232 Follow-up hospital inpatient care per day, typically 25 minutes Facility 2022 149 430 $68,455 $27,641 40.4%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 149 333 $100,665 $22,663 22.5%
99291 Critical care, first 30-74 minutes Facility 2022 42 117 $75,474 $22,225 29.4%
99233 Follow-up hospital inpatient care per day, typically 35 minutes Facility 2022 92 185 $42,114 $16,844 40.0%
99223 Initial hospital inpatient care per day, typically 70 minutes Facility 2022 81 83 $36,556 $14,363 39.3%
90961 Dialysis services, 2-3 physician visits per month (20 years or older) Office 2022 20 40 $27,060 $10,975 40.6%
90935 Hemodialysis procedure with physician evaluation Facility 2022 74 144 $23,220 $9,247 39.8%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2022 41 105 $44,639 $3,041 6.8%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2022 15 15 $5,820 $1,665 28.6%
99443 Telephone medical discussion with physician, 21-30 minutes Office 2022 13 16 $4,792 $740.10 15.4%
90960 Dialysis services (4 or more physician visits per month), patient 20 years of age and older Office 2021 40 227 $181,980 $73,032 40.1%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 159 364 $110,216 $40,418 36.7%
99232 Subsequent hospital inpatient care, typically 25 minutes per day Facility 2021 173 608 $95,435 $38,701 40.6%
99291 Critical care delivery critically ill or injured patient, first 30-74 minutes Facility 2021 61 150 $95,000 $28,468 30.0%

About Dr. Warren Chang, MD

Dr. Warren Chang, MD is a Nephrology healthcare provider based in Daly City, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/27/2006. The National Provider Identifier (NPI) number assigned to this provider is 1083674550.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Warren Chang, MD has received a total of $4,734 in payments from pharmaceutical and medical device companies, with $1,421 received in 2024. These payments were reported across 216 transactions from 26 companies. The most common payment nature is "Food and Beverage" ($4,676).

As a Medicare-enrolled provider, Chang has provided services to 3,053 Medicare beneficiaries, totaling 7,585 services with total Medicare billing of $883,281. Data is available for 4 years (2020–2023), covering 49 distinct procedure/service records.

Practice Information

  • Specialty Nephrology
  • Location Daly City, CA
  • Active Since 03/27/2006
  • Last Updated 08/26/2019
  • Taxonomy Code 207RN0300X
  • Entity Type Individual
  • Practice Solo Practitioner
  • NPI Number 1083674550

Products in Payments

  • LOKELMA (Drug) $548.94
  • JYNARQUE (Drug) $530.29
  • FARXIGA (Drug) $506.53
  • Veltassa (Drug) $375.59
  • Velphoro (Drug) $322.62
  • ACTHAR (Biological) $294.83
  • Parsabiv (Drug) $226.81
  • Kerendia (Drug) $211.56
  • INVOKANA (Drug) $208.07
  • Aranesp (Biological) $149.47
  • TARPEYO (Drug) $129.91
  • KRYSTEXXA (Biological) $129.25
  • Parsabiv (Biological) $118.47
  • JARDIANCE (Drug) $113.74
  • Ozempic (Drug) $100.59
  • Fabhalta (Drug) $97.25
  • LifeVest (Device) $70.83
  • EPOGEN (Biological) $59.86
  • RAYALDEE (Drug) $58.62
  • XARELTO (Drug) $52.54

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Nephrology Doctors in Daly City